Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-016578
Filing Date
2013-03-21
Accepted
2013-03-21 11:01:08
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v336076_10k.htm 10-K 654521
2 EXHIBIT 23.1 v336076_ex23-1.htm EX-23.1 3599
3 EXHIBIT 23.2 v336076_ex23-2.htm EX-23.2 3382
4 EXHIBIT 31.1 v336076_ex31-1.htm EX-31.1 7805
5 EXHIBIT 31.2 v336076_ex31-2.htm EX-31.2 7875
6 EXHIBIT 32.1 v336076_ex32-1.htm EX-32.1 4698
7 EXHIBIT 32.2 v336076_ex32-2.htm EX-32.2 4875
  Complete submission text file 0001144204-13-016578.txt   4258429

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT enmd-20121231.xml EX-101.INS 466648
9 XBRL TAXONOMY EXTENSION SCHEMA enmd-20121231.xsd EX-101.SCH 46127
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enmd-20121231_cal.xml EX-101.CAL 36874
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enmd-20121231_def.xml EX-101.DEF 211854
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE enmd-20121231_lab.xml EX-101.LAB 383234
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enmd-20121231_pre.xml EX-101.PRE 269226
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
ENTREMED INC (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 13706758
SIC: 2836 Biological Products, (No Diagnostic Substances)